Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$103.00K$103.00Kderived+3.0% vs Q4 2017 Net Income-$3.64M-$3.64MderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$3,660,000N/M Operating Cash Flowderived-$3,246,000N/M Free Cash Flowderived-$3,261,000N/M Margins · derivedOperating margin-3553.4%−30.4 pt vs Q4 2017
Net margin-3535.9%−49.9 pt vs Q4 2017
ended Dec 31, 2018 · filed Apr 2, 2019 · 92 d after period end